Loading patent…
AssigneePharmbio Korea Co., Ltd.
InventorsBong Kil NAM, Jun Sang NAM, Hyun Jung JUNG, Hyun Il KIM, Kyung Su LEE
Estimating the term…
The present invention can provide a colonic purgative tablet and a colonic purgative comprising same, the tablet having a gel-forming coating layer, which contains alginate as a main component, introduced into an uncoated tablet containing an osmotic material, so that, while damage to the gastric mucosa due to physical collision between the tablet and the gastric mucosa is be prevented, the osmotic material contained in the uncoated tablet rapidly disintegrates, and thus an excellent bowel cleansing effect is provided. The colonic purgative tablet according to the present invention can exhibit an excellent bowel cleansing effect even in small doses, and can further improve medication compliance through selective miniaturization of the tablet or introduction of an adhesive improvement coating layer.
A colonic purgative tablet comprising:
A pharmaceutical composition for colonic purgative, wherein on the day before the colonoscopy, 160 tablets of the colonic purgative tablet of claim 1 claim 1 and 425 ml of water are taken, then 850 ml of water is taken in two additional doses of 425 ml each, and on the day of the colonoscopy, colonic purgative tablets and water are repeatedly taken in the same manner as above, and the total dose of the colonic purgative is 38 to 55 g.
A pharmaceutical composition for colonic purgative, wherein on the day of the colonoscopy, 160 tablets of the colonic purgative tablet of claim 1 claim 1 and 425 ml of water are taken, then 850 ml of water is taken in two additional doses of 425 ml each, and the total dose of the colonic purgative is 38 to 55 g.
Dependencies are inferred from the claim text.